Streetbeat News

Analyst Ratings

PYPL

Analysts have published 17 ratings on PayPal Holdings (NASDAQ:PYPL) in the last three months, with a diverse range of perspectives. The average 12-month price target is $72.41, down 18.36% from the previous average. Recent actions include adjustments to ratings and price targets by analysts from firms like Susquehanna, Mizuho, and Morgan Stanley. PayPal's financials show a market cap that asserts dominance, a revenue growth rate of 8.36%, a net margin of 13.75%, an ROE of 5.18%, an ROA of 1.35%, and a debt-to-equity ratio of 0.54.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 8:00 pm

AR

Antero Resources (NYSE:AR) received mixed analyst ratings with 3 bullish, 1 somewhat bullish, and 2 indifferent. The average 12-month price target is $27.83, down 16.17% from the previous $33.20. Analysts from Raymond James, Benchmark, Mizuho, Wells Fargo, and Truist Securities have adjusted their ratings and price targets. Antero Resources is engaged in natural gas and liquids production, with a market cap below industry average, a -56.22% revenue decline as of September 30, 2023, low net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 24, 2024 | 8:00 pm

CTRA

Raymond James analyst John Freeman has maintained an Outperform rating on Coterra Energy (NYSE:CTRA) and increased the price target from $32 to $34.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 7:59 pm

BA

DAL

UAL

BofA Securities analyst Andrew G. Didora maintained a Buy rating on United Airlines Holdings, Inc. (UAL) and raised the price target to $60 from $56, despite concerns over Boeing's 737 MAX 9 grounding affecting UAL's capacity growth. United Airlines' shares rose by 5% after a strong Q4 earnings beat and positive 2024 EPS outlook. However, the company faces cost pressures from labor, maintenance, and the MAX 9 grounding. These pressures are expected to increase 2024 unit costs to +4.0% from the previously forecasted +2.2%. UAL shares were up 0.89% to $40.85.

Portfolio Pulse from Nabaparna Bhattacharya

January 24, 2024 | 7:58 pm

HLNE

Morgan Stanley analyst Michael Cyprys has maintained an Equal-Weight rating on Hamilton Lane (NASDAQ:HLNE) and increased the price target from $102 to $126.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 7:58 pm

COP

Raymond James analyst John Freeman has maintained a Strong Buy rating on ConocoPhillips (NYSE:COP) but has reduced the price target from $140 to $137.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 7:57 pm

CG

Morgan Stanley analyst Michael Cyprys has maintained an Equal-Weight rating on Carlyle Group (NASDAQ:CG) and increased the price target from $34 to $40.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 7:56 pm

APA

Raymond James analyst John Freeman has maintained a Strong Buy rating on APA Corporation (NASDAQ:APA) but has reduced the price target from $44 to $43.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 7:56 pm

BIIB

REGN

VRTX

UBS downgraded Biogen Inc (NASDAQ:BIIB) from Buy to Neutral with a lower price target of $276, citing slower market penetration for its Alzheimer's drug Leqembi. Challenges in neurologist access and uptake have led to reduced sales forecasts for 2024/25. Despite a positive view on Biogen's new CEO and strategy, UBS sees limited short-term stock performance benefits and recommends stocks with higher growth potential like Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). BIIB shares fell 1.10% to $248.75.

Portfolio Pulse from Vandana Singh

January 24, 2024 | 7:55 pm

AR

Raymond James analyst John Freeman has reaffirmed a Strong Buy rating on Antero Resources (NYSE:AR) and increased the price target from $28 to $32. This adjustment reflects a positive outlook on the company's stock, suggesting potential upside from the previous target.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 7:55 pm